Nutriband (NTRB) Financials: Revenue & Earnings

NTRB price $6.49 +0.54 +9.08%

Ticker
NTRB
Price
$6.49
Change
+0.54 +9.08%
Market cap ?
$78.89M
Beta ?
1.93
Sector
Healthcare
Industry
Biotechnology

Fair value

NTRB fair value $31.42. Price $6.49. Price is 79% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 480.98K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 12.16M. Net debt -4.33M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare NTRB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-12-07———465.00K
2026-09-04-0.07—437.51K437.51K
2026-06-11-0.10-1.89433.40K765.00K
2026-04-29-0.04-1.89400.71K765.00K
2025-12-16-0.12-2.13346.06K675.00K
2025-09-09-2.12-0.17622.00K622.00K
2025-05-30-0.12-0.13667.00K667.00K
2025-04-28-0.50-0.12642.00K642.00K
2024-12-03-0.12-0.12646.00K710.00K
2024-09-03-0.12-0.05442.83K675.00K
2024-05-31-0.21-0.07408.53K563.16K
2024-04-30-0.16-0.07524.61K563.16K
2023-12-12-0.22-0.12427.84K456.10K
2023-09-11-0.11-0.08655.93K477.91K
2023-06-09-0.13-0.22476.93K455.76K
2023-04-26-0.21-0.05527.53K675.00K
2022-12-02-0.14-0.07620.00K563.16K
2022-09-07-0.12-0.07456.12K456.10K
2022-05-31-0.08-0.06477.91K477.91K
2022-04-29-0.20-0.09491.89K455.76K
2021-12-14-0.23-0.03283.04K890.00K
2021-09-03-0.070.01213.74K1.92M
2021-06-14-0.04-0.08433.49K100.00K
2021-04-02-0.33-0.08348.09K100.00K
2020-12-15-0.01-0.03391.80K617.08K
2020-09-11-0.03-0.0684.45K119.40K
2020-06-04-0.28-0.11119.36K100.00K
2020-04-14-0.15-0.0819.58K82.60K
2019-12-12-0.12-0.0782.57K74.90K
2019-09-12-0.07-0.1074.91K193.60K
2019-06-13-0.090.03193.59K600.00K
2019-04-19-0.080.0382.47K600.00K
2018-12-14-0.08—162.81K—
2018-09-17-0.30———
2018-06-18-0.07———
2018-05-01-0.40———
2017-12-08-0.02———
2017-09-19-0.02———
2017-06-19-0.01———
2017-05-05-0.01———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2025-01-31Sheridan GarethOther0——
2025-01-29Sheridan GarethBuy29.33K$8.07236.72K
2025-01-23Goodman GeraldBuy17.67K$7.34129.68K
2024-06-06Goodman GeraldBuy87.50K$1.93168.88K
2024-06-05Goodman GeraldSell60.09K$1.93115.96K
2024-03-20Sheridan GarethBuy97.50K$2.61254.47K
2024-03-20Goodman GeraldBuy75.00K$2.37177.75K
2024-03-20MELNIK SERGUEIBuy97.50K$2.61254.47K
2024-03-20Sheridan GarethBuy75.00K$2.37177.75K
2024-03-19Goodman GeraldBuy75.00K$1.93144.75K
2023-10-27Goodman GeraldBuy60.09K$1.93115.96K
2023-10-27Goodman GeraldBuy49.50K$1.9395.53K
2023-03-06MELNIK SERGUEISell5.00K——
2022-12-09Goodman GeraldBuy20.00K$3.5370.60K
2022-08-16Goodman GeraldBuy23.33K$4.0995.43K
2022-05-10Sheridan GarethBuy10.00K$3.8038.00K
2022-05-10Sheridan GarethSell10.00K$3.8038.00K
2022-02-24MELNIK SERGUEIBuy500$4.032.02K
2022-02-24MELNIK SERGUEISell500$4.032.02K
2022-02-24MELNIK SERGUEISell5.00K$4.0320.15K
2022-02-06MELNIK SERGUEISell10.00K——
2022-01-21Goodman GeraldBuy11.17K$4.1646.45K
2022-01-21MELNIK SERGUEIBuy23.33K$4.58106.87K
2022-01-21Sheridan GarethBuy23.33K$4.58106.87K
2022-01-21MELNIK SERGUEIBuy20.00K$5.34106.80K
2022-01-21Sheridan GarethBuy20.00K$5.34106.80K
2021-10-22Goodman GeraldBuy87.50K$1.93168.88K
2021-01-31Sheridan GarethOther0——
2021-01-05Sheridan GarethBuy10.00K$15.00150.00K
2019-05-30MELNIK SERGUEISell20.00K——
2019-01-10Goodman GeraldBuy26.25K$25.37665.96K
2018-07-31Davidov MichaelBuy5.00K——
2018-05-31Davidov MichaelOther0——
2018-01-31MELNIK SERGUEIOther0——
2018-01-31MELNIK SERGUEISell0——
2018-01-31MELNIK SERGUEIOther0——
2018-01-31MELNIK SERGUEIOther0——
2018-01-31MELNIK SERGUEIOther0——
2018-01-31MELNIK SERGUEIOther0——
2018-01-31Sheridan GarethOther0——
2017-08-19MELNIK SERGUEISell450.00K$0.00450
2017-08-17Sheridan GarethSell1.00M$0.001.00K
2017-08-09Sheridan GarethSell1.00M——
2017-01-31MELNIK SERGUEIOther0——
2017-01-31Botgros VitalieOther0——
2017-01-31Sheridan GarethOther0——
2016-11-30Sheridan GarethSell7.00M$0.007.00K
2016-01-15MELNIK SERGUEIBuy3.00M$0.003.00K
2016-01-15Botgros VitalieBuy3.00M$0.003.00K
2016-01-15Sheridan GarethBuy11.50M$0.0011.50K
2016-01-15Sheridan GarethBuy2.50M$0.002.50K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 16, holders +2 vs prior quarter. Ownership 2.90%.

HolderSharesChangeChange %Value
VANGUARD CAPITAL MANAGEMENT LLC174.93K00.00%558.02K
GEODE CAPITAL MANAGEMENT, LLC62.49K-7.56K-10.79%199.40K
VANGUARD FIDUCIARY TRUST CO25.11K00.00%80.10K
STATE STREET CORP24.97K00.00%79.64K
CITADEL ADVISORS LLC19.00K19.00KNew60.60K
NORTHERN TRUST CORP11.57K-2.38K-17.03%36.91K
HAVEN PRIVATE, LLC11.37K00.00%36.26K
BLACKROCK, INC.10.66K1.12K+11.75%34.01K
OSAIC HOLDINGS, INC.3.68K-1.17K-24.06%11.75K
VANGUARD GLOBAL ADVISERS, LLC2.70K00.00%8.61K
WELLS FARGO & COMPANY/MN2.60K00.00%8.29K
TOWER RESEARCH CAPITAL LLC (TRC)2.11K1.08K+104.56%6.72K
UBS GROUP AG672-31.99K-97.94%2.14K
JONES FINANCIAL COMPANIES LLLP46600.00%1.43K
BARCLAYS PLC1919New61
HARBOUR INVESTMENTS, INC.300.00%10

Earnings and financials

Nutriband Inc. (NTRB) trades at $6.49, with a market cap of $78.89M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Nutriband (NTRB) Financials: Revenue & Earnings

NTRB$6.49+0.54 +9.08%

$78.89M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History